HR 1254 EHRFSCommentsClose CommentsPermalink

112th CONGRESSCommentsClose CommentsPermalink

1st SessionCommentsClose CommentsPermalink

H. R. 1254CommentsClose CommentsPermalink

IN THE SENATE OF THE UNITED STATESCommentsClose CommentsPermalink

December 8, 2011CommentsClose CommentsPermalink

Received; read twice and referred to the Committee on the JudiciaryCommentsClose CommentsPermalink

---

AN ACTCommentsClose CommentsPermalink

To amend the Controlled Substances Act to place synthetic drugs in Schedule I.CommentsClose CommentsPermalink

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, CommentsClose CommentsPermalink

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘Synthetic Drug Control Act of 2011’.CommentsClose CommentsPermalink

SEC. 2. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.

(a) Cannabimimetic Agents- Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:CommentsClose CommentsPermalink





‘(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.CommentsClose CommentsPermalink





‘(2) In paragraph (1):CommentsClose CommentsPermalink





‘(A) The term ‘cannabimimetic agents’ means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:CommentsClose CommentsPermalink





‘(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.CommentsClose CommentsPermalink





‘(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.CommentsClose CommentsPermalink





‘(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.CommentsClose CommentsPermalink





‘(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.CommentsClose CommentsPermalink





‘(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.CommentsClose CommentsPermalink





‘(B) Such term includes--CommentsClose CommentsPermalink





‘(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);CommentsClose CommentsPermalink





‘(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);CommentsClose CommentsPermalink





‘(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);CommentsClose CommentsPermalink





‘(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);CommentsClose CommentsPermalink





‘(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);CommentsClose CommentsPermalink





‘(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);CommentsClose CommentsPermalink





‘(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);CommentsClose CommentsPermalink





‘(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);CommentsClose CommentsPermalink





‘(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);CommentsClose CommentsPermalink





‘(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);CommentsClose CommentsPermalink





‘(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);CommentsClose CommentsPermalink





‘(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);CommentsClose CommentsPermalink





‘(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);CommentsClose CommentsPermalink





‘(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8); andCommentsClose CommentsPermalink





‘(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).’.CommentsClose CommentsPermalink





(b) Other Drugs- Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:CommentsClose CommentsPermalink





‘(18) 4-methylmethcathinone (Mephedrone).CommentsClose CommentsPermalink





‘(19) 3,4-methylenedioxypyrovalerone (MDPV).CommentsClose CommentsPermalink





‘(20) 3,4-methylenedioxymethcathinone (methylone).CommentsClose CommentsPermalink





‘(21) Naphthylpyrovalerone (naphyrone).CommentsClose CommentsPermalink





‘(22) 4-fluoromethcathinone (flephedrone).CommentsClose CommentsPermalink





‘(23) 4-methoxymethcathinone (methedrone; Bk-PMMA).CommentsClose CommentsPermalink





‘(24) Ethcathinone (N-Ethylcathinone).CommentsClose CommentsPermalink





‘(25) 3,4-methylenedioxyethcathinone (ethylone).CommentsClose CommentsPermalink





‘(26) Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (butylone).CommentsClose CommentsPermalink





‘(27) N,N-dimethylcathinone (metamfepramone).CommentsClose CommentsPermalink





‘(28) Alpha-pyrrolidinopropiophenone (alpha-PPP).CommentsClose CommentsPermalink





‘(29) 4-methoxy-alpha-pyrrolidinopropiophenone (MOPPP).CommentsClose CommentsPermalink





‘(30) 3,4-methylenedioxy-alphapyrrolidinopropiophenone (MDPPP).CommentsClose CommentsPermalink





‘(31) Alpha-pyrrolidinovalerophenone (alpha-PVP).CommentsClose CommentsPermalink





‘(32) 6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI).CommentsClose CommentsPermalink





‘(33) 3-fluoromethcathinone.CommentsClose CommentsPermalink





‘(34) 4’-Methyl-a-pyrrolidinobutiophenone (MPBP).CommentsClose CommentsPermalink





‘(35) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).CommentsClose CommentsPermalink





‘(36) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).CommentsClose CommentsPermalink





‘(37) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).CommentsClose CommentsPermalink





‘(38) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).CommentsClose CommentsPermalink





‘(39) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).CommentsClose CommentsPermalink





‘(40) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).CommentsClose CommentsPermalink





‘(41) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).CommentsClose CommentsPermalink





‘(42) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).CommentsClose CommentsPermalink





‘(43) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).’.CommentsClose CommentsPermalink

SEC. 3. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.

Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended--CommentsClose CommentsPermalink





(1) by striking ‘one year’ and inserting ‘2 years’; andCommentsClose CommentsPermalink





(2) by striking ‘six months’ and inserting ‘1 year’.CommentsClose CommentsPermalink

Passed the House of Representatives December 8, 2011.CommentsClose CommentsPermalink

Attest:CommentsClose CommentsPermalink

Clerk.

Clerk.CommentsClose CommentsPermalink